Related Experiment Video
Updated: May 23, 2026

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
Published on: September 24, 2021
Persistent atrial fibrillation is associated with a poor prognosis in patients with atrioventricular block and
Dubravko Petrač1, Vjekoslav Radeljić, Diana Delić-Brkljačić
1Bogdan Cardiology Polyclinic, Zagreb, Croatia. d.petrac@inet-hr
Insights
Persistent atrial fibrillation (AF) in patients with AV block and DDD pacemakers increases cardiovascular death risk, particularly from heart failure. This finding highlights the importance of monitoring for AF in this patient population.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Device Research
Background:
- Prognostic impact of persistent atrial fibrillation (AF) in patients with atrioventricular (AV) block and dual chamber (DDD) pacemakers is understudied.
- Investigating the influence of persistent AF on clinical outcomes in this specific patient group.
Purpose of the Study:
- To determine if persistent AF development impacts clinical outcomes in patients with AV block and DDD pacemakers.
Main Methods:
- Retrospective analysis of 308 patients with AV block and DDD pacemakers followed for 36 months.
- Comparison of clinical outcomes between 34 patients with persistent AF and 278 patients without persistent AF.
- Primary outcome assessed was cardiovascular death.
Main Results:
- Higher incidence of cardiovascular death in the persistent AF group (6.8% per year) versus the control group (2.9% per year; P=0.028).
- Increased heart failure-related deaths (P=0.009) and hospitalizations for heart failure (P=0.008) in the persistent AF group.
- No significant difference in nonfatal stroke risk between groups (P=0.628).
Conclusions:
- Development of persistent AF in patients with AV block and DDD pacemakers is linked to elevated cardiovascular death risk.
- Persistent AF is associated with an increased risk of heart failure and related mortality in this population.
Background:
The prognostic significance of development of persistent atrial fibrillation (AF) in patients with atrioventricular (AV) block and dual chamber (DDD) pacemakers has not been separately investigated. We sought to determine whether persistent AF influences clinical outcome in these patients.
Methods:
Three hundred-eight consecutive patients with second- or third-degree AV block and implanted a DDD pacemaker were followed for 36 ± 20 months and retrospectively divided into two groups. Thirty-four patients who developed persistent AF formed persistent AF group, and 278 patients who remained free of this arrhythmia control group. Clinical and outcome data of the two groups were compared. The primary outcome was cardiovascular death.
Results:
The primary outcome occurred more often among the patients in the persistent AF group (6.8% per year) than among those in the control group (2.9% per year; P = 0.028). This difference was primarily because of higher rate of heart failure-related deaths in the persistent AF group (P = 0.009). Secondary outcomes, hospitalization for heart failure and paroxysmal AF episode ≥5 minutes, occurred also more often among the patients in the persistent AF group (P = 0.008 and P < 0.001, respectively), although the risk of nonfatal stroke was similar in both groups (P = 0.628).
Conclusion:
In patients with second- or third-degree AV block and DDD pacemaker, the development of persistent AF is associated with an increased risk of cardiovascular death and heart failure.
More Related Videos
Related Concept Videos
Dysrhythmias IV: Characteristics of Bradyarrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

